200 related articles for article (PubMed ID: 22504013)
1. Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells.
Mingeot-Leclercq MP; Tulkens PM; Denamur S; Vaara T; Vaara M
Peptides; 2012 Jun; 35(2):248-52. PubMed ID: 22504013
[TBL] [Abstract][Full Text] [Related]
2. A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
Vaara M; Siikanen O; Apajalahti J; Fox J; Frimodt-Møller N; He H; Poudyal A; Li J; Nation RL; Vaara T
Antimicrob Agents Chemother; 2010 Aug; 54(8):3341-6. PubMed ID: 20479195
[TBL] [Abstract][Full Text] [Related]
3. The novel polymyxin derivative NAB739 is remarkably less cytotoxic than polymyxin B and colistin to human kidney proximal tubular cells.
Vaara M; Vaara T
Int J Antimicrob Agents; 2013 Mar; 41(3):292-3. PubMed ID: 23182536
[No Abstract] [Full Text] [Related]
4. Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Vaara M; Fox J; Loidl G; Siikanen O; Apajalahti J; Hansen F; Frimodt-Møller N; Nagai J; Takano M; Vaara T
Antimicrob Agents Chemother; 2008 Sep; 52(9):3229-36. PubMed ID: 18591267
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens.
Vaara M; Sader HS; Rhomberg PR; Jones RN; Vaara T
J Antimicrob Chemother; 2013 Mar; 68(3):636-9. PubMed ID: 23134658
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies on novel polymyxin derivatives that carry only three positive charges.
Vaara M; Vaara T
Peptides; 2010 Dec; 31(12):2318-21. PubMed ID: 20868714
[TBL] [Abstract][Full Text] [Related]
7. Polymyxin B Nephrotoxicity: From Organ to Cell Damage.
Vattimo Mde F; Watanabe M; da Fonseca CD; Neiva LB; Pessoa EA; Borges FT
PLoS One; 2016; 11(8):e0161057. PubMed ID: 27532263
[TBL] [Abstract][Full Text] [Related]
8. Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity.
Weber EJ; Lidberg KA; Wang L; Bammler TK; MacDonald JW; Li MJ; Redhair M; Atkins WM; Tran C; Hines KM; Herron J; Xu L; Monteiro MB; Ramm S; Vaidya V; Vaara M; Vaara T; Himmelfarb J; Kelly EJ
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568031
[TBL] [Abstract][Full Text] [Related]
9. Novel derivatives of polymyxins.
Vaara M
J Antimicrob Chemother; 2013 Jun; 68(6):1213-9. PubMed ID: 23412346
[TBL] [Abstract][Full Text] [Related]
10. Major pathways of polymyxin-induced apoptosis in rat kidney proximal tubular cells.
Azad MA; Akter J; Rogers KL; Nation RL; Velkov T; Li J
Antimicrob Agents Chemother; 2015 Apr; 59(4):2136-43. PubMed ID: 25624331
[TBL] [Abstract][Full Text] [Related]
11. Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics.
Vaara M
Molecules; 2019 Jan; 24(2):. PubMed ID: 30641878
[TBL] [Abstract][Full Text] [Related]
12. Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice.
Vingsbo Lundberg C; Vaara T; Frimodt-Møller N; Vaara M
J Antimicrob Chemother; 2010 May; 65(5):981-5. PubMed ID: 20233777
[TBL] [Abstract][Full Text] [Related]
13. Cellular Uptake and Localization of Polymyxins in Renal Tubular Cells Using Rationally Designed Fluorescent Probes.
Yun B; Azad MA; Nowell CJ; Nation RL; Thompson PE; Roberts KD; Velkov T; Li J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7489-96. PubMed ID: 26392495
[TBL] [Abstract][Full Text] [Related]
14. Polymyxin derivatives: a patent evaluation (WO2012168820).
Wu H; Teng P; Niu Y; Li Q; Cai J
Expert Opin Ther Pat; 2013 Aug; 23(8):1075-81. PubMed ID: 23806121
[TBL] [Abstract][Full Text] [Related]
15. Polymyxin B causes DNA damage in HK-2 cells and mice.
Yun B; Zhang T; Azad MAK; Wang J; Nowell CJ; Kalitsis P; Velkov T; Hudson DF; Li J
Arch Toxicol; 2018 Jul; 92(7):2259-2271. PubMed ID: 29556720
[TBL] [Abstract][Full Text] [Related]
16. New polymyxin derivatives that display improved efficacy in animal infection models as compared to polymyxin B and colistin.
Vaara M
Med Res Rev; 2018 Sep; 38(5):1661-1673. PubMed ID: 29485690
[TBL] [Abstract][Full Text] [Related]
17. Polymyxins and their novel derivatives.
Vaara M
Curr Opin Microbiol; 2010 Oct; 13(5):574-81. PubMed ID: 20869908
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies on polymyxin derivatives carrying three positive charges only reveal a new class of compounds with strong antibacterial activity.
Vaara M; Vaara T; Tyrrell JM
Peptides; 2017 May; 91():8-12. PubMed ID: 28300674
[TBL] [Abstract][Full Text] [Related]
20. The renaissance of polymyxins.
Kadar B; Kocsis B; Nagy K; Szabo D
Curr Med Chem; 2013; 20(30):3759-73. PubMed ID: 23895690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
